Contango Ore (AMEX:CTGO) reported quarterly losses of $(2.10) per share which missed the analyst consensus estimate of $(0.91) by 130.77 percent. This is a 191.67 percent decrease over losses of $(0.72) per share from the same period last year.
Omeros Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use In Nine Patients With Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy
Omeros Corporation (NASDAQ:OMER) today announced the upcoming presentation of a report detailing narsoplimab treatment in nine adult patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy
